These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Immunoregulation of tumor growth in a murine model]. de Bonaparte YP; Colombo L; Davel L; Diament M; Eiján AM; Jasnis MA; Klein S; de Kohan SS; Oisgold-Daga S; Stillitani I Medicina (B Aires); 1989; 49(3):265-70. PubMed ID: 2487420 [TBL] [Abstract][Full Text] [Related]
6. Enhancement of the incidence of metastasis in tumor-resected mice. Influence of soluble tumor extract and splenectomy. Klein S; de Bonaparte YP; de D'Elia I Invasion Metastasis; 1985; 5(5):309-16. PubMed ID: 4030247 [TBL] [Abstract][Full Text] [Related]
7. Augmentation of lymphoproliferative activity of tumor-bearing BALB/c mice to soluble tumor antigens by surgical manipulation: the possible role of macrophages. Laing CA; Japal KM; Baker ME J Surg Oncol; 1987 May; 35(1):1-6. PubMed ID: 3573770 [TBL] [Abstract][Full Text] [Related]
8. Effects of Chlorella vulgaris on tumor growth in mammary tumor-bearing Balb/c mice: discussing association of an immune-suppressed protumor microenvironment with serum IFNγ and IgG decrease and spleen IgG potentiation. Khalilnezhad A; Mahmoudian E; Mosaffa N; Anissian A; Rashidi M; Amani D Eur J Nutr; 2018 Apr; 57(3):1025-1044. PubMed ID: 28229276 [TBL] [Abstract][Full Text] [Related]
9. Reactivity of subpopulations of mouse spleen cells to concanavalin A in vitro. Laing CA; Walters CS Med Pediatr Oncol; 1983; 11(4):233-7. PubMed ID: 6888322 [TBL] [Abstract][Full Text] [Related]
10. Inhibitory effect of tumor-bearing state on the generation of in vivo protective immune T cells in a syngeneic murine tumor system. Fujiwara H; Hamaoka T; Nishino Y; Kitagawa M Gan; 1977 Oct; 68(5):589-601. PubMed ID: 73490 [TBL] [Abstract][Full Text] [Related]
11. Cell therapy with preimmunized effector cells mismatched for minor histocompatible antigens in the treatment of a murine mammary carcinoma. Morecki S; Yacovlev E; Gelfand Y; Uzi I; Slavin S J Immunother; 2001; 24(2):114-21. PubMed ID: 11265768 [TBL] [Abstract][Full Text] [Related]
12. An immunoregulatory factor associated with spleen cells from tumor-bearing animals. I. Effect on tumor growth and antibody production. Isakov N; Segal S; Hollander N; Feldman M Int J Cancer; 1978 Oct; 22(4):465-70. PubMed ID: 359490 [TBL] [Abstract][Full Text] [Related]
13. Interleukin 18 induces the sequential activation of natural killer cells and cytotoxic T lymphocytes to protect syngeneic mice from transplantation with Meth A sarcoma. Micallef MJ; Tanimoto T; Kohno K; Ikeda M; Kurimoto M Cancer Res; 1997 Oct; 57(20):4557-63. PubMed ID: 9377569 [TBL] [Abstract][Full Text] [Related]
14. [Ambiguous action of splenocytes from tumor-bearing mice on the formation of metastases in the lungs of mice in an adaptive transfer system]. Iunker VM; Arkhipov SA; Gruntenko EV Biull Eksp Biol Med; 1984 Nov; 98(11):598-600. PubMed ID: 6509179 [TBL] [Abstract][Full Text] [Related]
15. In situ lymphoid cells of mouse mammary tumors. IV. Comparison of functional activity of lymphoid cells separated from mammary tumors to that of spleen and lymph node cells of tumor-sensitized mice. Ruppert B; Blazar B; Medina D; Heppner G J Immunol; 1979 Jun; 122(6):2180-3. PubMed ID: 448122 [TBL] [Abstract][Full Text] [Related]
16. Lymphocyte-induced angiogenesis: correlation with the metastatic incidence of two murine mammary adenocarcinomas. Miguez M; Davel L; de Lustig ES Invasion Metastasis; 1986; 6(5):313-20. PubMed ID: 2430911 [TBL] [Abstract][Full Text] [Related]
17. NK cells from mammary tumor bearing mice do not exert natural killer activity but function as antibody dependent cellular cytotoxicity effectors. Rivera LM; Lopez DM Anticancer Res; 1993; 13(1):177-84. PubMed ID: 8476211 [TBL] [Abstract][Full Text] [Related]
18. Role of tumor-derived cytokines on the immune system of mice bearing a mammary adenocarcinoma. II. Down-regulation of macrophage-mediated cytotoxicity by tumor-derived granulocyte-macrophage colony-stimulating factor. Sotomayor EM; Fu YX; Lopez-Cepero M; Herbert L; Jimenez JJ; Albarracin C; Lopez DM J Immunol; 1991 Oct; 147(8):2816-23. PubMed ID: 1918995 [TBL] [Abstract][Full Text] [Related]
19. Immune reactivity of spleen cells in advanced stages of tumor growth. Oisgold-Dagá S; Jasnis MA; Klein S; de Bonaparte YP Biomed Pharmacother; 1982; 36(6-7):319-23. PubMed ID: 6763881 [TBL] [Abstract][Full Text] [Related]
20. Antibody in the sera of tumor-bearing mice that mediates spleen cell cytotoxicity toward the autologous tumor. Blair PB; Lane MA; Mar P J Immunol; 1976 Mar; 116(3):606-9. PubMed ID: 176266 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]